Visipaque 320 652 mg (Iodixanol SOLUTION) 652 MG

VISIPAQUE 320 652 MG is a radiocontrast agent used for diagnostic imaging procedures. This iodixanol solution is designed for intra-arterial administration, providing clear visualization of blood vessels.

Strength

652 MG

Pack Size

50/100/200/500 ML

Manufacturer / TM Owner

GE HEALTHCARE CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VISIPAQUE 320 652 MG is primarily used in medical imaging to enhance the visibility of blood vessels during procedures like angiography. It helps healthcare professionals to assess blood flow and identify potential issues. The solution is administered intra-arterially, making it suitable for detailed vascular studies.

Side Effects

When administered, VISIPAQUE 320 652 MG may cause a temporary warming sensation or mild discomfort at the injection site. Some individuals might experience a metallic taste or a brief feeling of warmth throughout the body. These effects are generally short-lived and subside quickly.

Precautions & Warnings

VISIPAQUE 320 652 MG should be used with caution in individuals with a history of allergic reactions to iodinated contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper hydration is recommended before and after the procedure.

Avoid Interactions

VISIPAQUE 320 652 MG may interact with certain medications, particularly those that affect kidney function. It is advisable to discuss all current medications with a healthcare provider before using this contrast agent. Alcohol consumption should be avoided before and after the procedure to minimize potential side effects.

Frequently Asked Questions

VISIPAQUE 320 652 MG is used as a radiocontrast agent to enhance the visibility of blood vessels during diagnostic imaging procedures like angiography.

VISIPAQUE 320 652 MG is administered intra-arterially, meaning it is injected directly into the arteries for detailed vascular imaging.

Common effects may include a temporary warming sensation, mild discomfort at the injection site, a metallic taste, or a brief feeling of warmth throughout the body.

Individuals with a history of allergic reactions to iodinated contrast media should use VISIPAQUE 320 652 MG with caution and inform their healthcare provider.

VISIPAQUE 320 652 MG may interact with medications that affect kidney function, so it is important to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.